Women's Wellbeing Study

September 19, 2025 updated by: Butler Hospital

Treatments for Improving Mood in Women

Phase 2 is a randomized controlled trial of integrative yoga and mindful self-compassion program vs. women's wellbeing education for women with a history of interpersonal violence exposure and heightened distress.

Study Overview

Detailed Description

In Phase 2, the investigators will conduct a pilot randomized controlled trial (RCT) of 12 weeks of integrative yoga and mindful self-compassion training (I-YMSC) vs. 12 weeks of women's wellbeing education (WWE).

Participants will be women with a history of interpersonal violence exposure and heightened distress.

Participants will be randomized to Phase 2 groups of 12 weeks of I-YMSC or WWE. Forty-eight women will be enrolled.

Study Type

Interventional

Enrollment (Estimated)

48

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Rhode Island
      • Providence, Rhode Island, United States, 02906
        • Recruiting
        • Butler Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Female
  2. Ages 18-65
  3. Report having experienced interpersonal violence (defined to include all forms throughout the lifespan, confirmed with the Trauma History Questionnaire (THQ])
  4. Report being distressed, defined by a score of >5 on the Kessler-6 screener
  5. Speak and understand English well enough to understand questionnaires when they are read aloud
  6. Have access to a telephone through owning one, a relative/friend, or an agency
  7. Have access to a device that will support use of the video platform we are using to conduct assessments and for home practice yoga video sessions

Exclusion Criteria:

  1. Inability to be physically active, determined by a score >1 on the Physical Activity Readiness Questionnaire (PAR-Q) and physician non-consent of participation
  2. Planned surgery in next 6 months, as this would interfere with study participation
  3. Pregnancy, as yoga should be modified for pregnancy

    Women who meet criteria for the following:

  4. Current mania as determined by the Diagnostic Interview for Anxiety, Mood, and OCD and Related Neuropsychiatric Disorders (DIAMOND)
  5. Lifetime history of psychotic disorders (DIAMOND)
  6. Current probable severe substance use disorder (DIAMOND)
  7. Current diagnosis of anorexia nervosa or history in past year (DIAMOND)
  8. Moderate or high risk for suicide on the adapted Columbia Suicide Severity Rating Scale screen version-recent (C-SSRS) and/or endorsement of suicidal plan/intent in the past 3 months
  9. Non-stable course of psychiatric treatments (medication, psychotherapy) for the last 8 weeks
  10. Plan to move from the area in the next 6 months, as this may preclude study participation given enrollment timeframes
  11. Self-report of experiencing intimate partner violence currently or within past six months (assessed by the Revised Conflict Tactics Scale 2 [R-CTS2]), as this would require a different type of intervention
  12. Current weekly yoga practice or current participation in mindfulness-based programming, as these are the study interventions

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Integrative Yoga and Mindful Self-Compassion (I-YMSC) training
12 weeks of I-YMSC training
Group Integrative Yoga & Mindful Self-Compassion training for women with a history of interpersonal violence exposure and distress
Active Comparator: Women's Wellbeing Education (WWE)
12 weeks of group WWE
Group women's wellbeing education for women with a history of interpersonal violence exposure and distress

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The Client Satisfaction Questionnaire (CSQ-8)
Time Frame: Post intervention (month 3)
Satisfaction with treatment assessed with The Client Satisfaction Questionnaire (CSQ-8). The CSQ-8 is an 8-item measure with each item measured on a 1-4 scale, and total score range from 8-32. Higher scores indicate greater client satisfaction.
Post intervention (month 3)
Systematic Assessment of Treatment-emergent Events-general Inquiry (SAFTEE)
Time Frame: Post intervention (month 3)
Participant safety/adverse events will be measured using the SAFTEE. Participants will also be asked weekly if they experienced any injuries as a result of yoga.
Post intervention (month 3)
Feasibility
Time Frame: Post intervention (month 3)
Feasibility assessed based on number of participants who remained in the intervention (retention).
Post intervention (month 3)
Feasibility of Intervention Measure
Time Frame: Post intervention (month 3)
The Feasibility of Intervention Measure (FIM) construct comprises four items with each item measured on a 1-5 scale. The total score range is from 4-20. Higher scores indicate greater feasibility.
Post intervention (month 3)
Intervention Appropriateness Measure
Time Frame: Post intervention (month 3)
The Intervention Appropriateness Measure (IAM) construct comprises four items with each item measured on a 1-5 scale. The total score range is from 4-20. Higher scores indicate greater feasibility.
Post intervention (month 3)
Acceptability of Intervention Measure
Time Frame: Post intervention (month 3)
The Acceptability of Intervention Measure (AIM) comprises four items with each item measured on a 1-5 scale. The total score range is from 4-20. Higher scores indicate greater feasibility.
Post intervention (month 3)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Depression Anxiety and Stress Scale (DASS-21)
Time Frame: Baseline to post intervention (month 3)
Distress at Month 3. The DASS-21 is a 21-item measure with each item measured on a 0-3 scale, and total score conversion ranging from 0-63. Higher global scores indicate greater psychological distress.
Baseline to post intervention (month 3)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 27, 2025

Primary Completion (Estimated)

May 31, 2027

Study Completion (Estimated)

May 31, 2027

Study Registration Dates

First Submitted

September 19, 2025

First Submitted That Met QC Criteria

September 19, 2025

First Posted (Estimated)

September 26, 2025

Study Record Updates

Last Update Posted (Estimated)

September 26, 2025

Last Update Submitted That Met QC Criteria

September 19, 2025

Last Verified

September 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • 1871144-2
  • K23AT011917 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe